A Tri-part Protein Complementation System Using Antibody-Small Peptide Fusions Enables Homogeneous Immunoassays.

about

A Tri-part Protein Complementation System Using Antibody-Small Peptide Fusions Enables Homogeneous Immunoassays.

Item

http://www.wikidata.org/entity/Q38642011

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A Tri-part Protein Complementa ...... bles Homogeneous Immunoassays.

@en

type

Item

label

A Tri-part Protein Complementa ...... bles Homogeneous Immunoassays.

@en

prefLabel

A Tri-part Protein Complementa ...... bles Homogeneous Immunoassays.

@en

P1476

A Tri-part Protein Complementa ...... bles Homogeneous Immunoassays.

@en

P2093

Andrew S Dixon

http://www.w3.org/2001/XMLSchema#string

Brett K Baumgartner

http://www.w3.org/2001/XMLSchema#string

Sun Jin Kim

http://www.w3.org/2001/XMLSchema#string

Sylvia Krippner

http://www.w3.org/2001/XMLSchema#string

P2860

Humanization of an anti-p185HER2 antibody for human cancer therapy

Energy transfer: a spectroscopic ruler

Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.

A Comparison of IHC and FISH Cytogenetic Methods in the Evaluation of HER2 Status in Breast Cancer

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

A designed ankyrin repeat protein evolved to picomolar affinity to Her2

Structure of the complex between HER2 and an antibody paratope formed by side chains from tryptophan and serine

Structural basis for high-affinity HER2 receptor binding by an engineered protein

Structural Insights into the Down-regulation of Overexpressed p185her2/neu Protein of Transformed Cells by the Antibody chA21

Structural basis for eliciting a cytotoxic effect in HER2-overexpressing cancer cells via binding to the extracellular domain of HER2

P2888

s41598-017-07569-y

P304

8186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-07569-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shawn C Owen

P577

2017-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091119455

http://www.w3.org/2001/XMLSchema#string

P698

28811487

http://www.w3.org/2001/XMLSchema#string

P932

5557857

http://www.w3.org/2001/XMLSchema#string